UNSPSC 51282811: Metronidazole hydrochloride

This classification denotes a trichomonacide agent and protein synthesis inhibitor with the molecular formula C6H9N3O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 76JC1633UF, chemically known as 1h-imidazole-1-ethanol, 2-methyl-5-nitro-, hydrochloride but more generally known as metronidazole hydrochloride, which bears US NIH Compound Identifier 68592. European Medicines Agency schedules Metronidazole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14570MIG.

UNSPSC 51282811 Metronidazole hydrochloride is a Commodity code for a specific pharmaceutical active ingredient, yet the recent state and local opportunities posted under this code do not reflect procurement of metronidazole itself. Instead, the available records show state and local governments sourcing naloxone, doxycycline hyclate, ciprofloxacin hydrochloride, and drug deactivation systems through piggyback contracts and competitive bids. The mismatch between the code's nominal scope and the work actually being tagged suggests either misclassification by issuing bodies or a significant gap between the taxonomy and current procurement practice for this pharmaceutical ingredient.

The issuing bodies in the recent record include a state health department and a county government. Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate and ciprofloxacin hydrochloride totaling $2,999,999.11 over the contract life, with an initial 12-month term and two renewal options. Seminole County, Florida posted an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county community health building, though the response deadline shown (July 26, 2023) predates the posting date. Activity appears concentrated in Florida and Illinois, though the small sample and taxonomic mismatch limit confidence in geographic characterization. No current open solicitations for metronidazole hydrochloride specifically appear in the recent record; the code shows little relevant activity aligned with its stated scope.